epidem
pandem
lethal
viral
pneumonia
period
occur
result
substanti
morbid
mortal
effect
treatment
lethal
viral
pneumonia
remain
lack
major
physiolog
role
human
nose
protect
rel
vulner
lung
first
point
contact
respiratori
tract
environ
nose
mani
uniqu
histolog
anatom
featur
allow
effect
filter
humidifi
warm
inhal
air
minim
detriment
stimul
lower
airway
lung
physicaltyp
protect
mechan
well
recogn
studi
littl
known
whether
nose
prime
immun
lung
therebi
protect
human
nose
import
branch
mucos
immun
system
mucos
surfac
cover
gastrointestin
gi
respiratori
urinari
genit
tract
function
immunolog
sensor
detect
danger
signal
includ
pathogen
recent
studi
shown
activ
gi
mucos
immun
system
contribut
local
immun
respons
also
regul
immun
function
distant
organ
includ
lung
brain
instanc
interact
gi
mucosa
microbiota
alter
cell
b
cell
respons
influenza
viru
iav
infect
similar
gi
system
human
nose
cover
type
mucosa
compris
singl
layer
epitheli
cell
abund
antigenpres
cell
apc
goblet
cell
special
mucos
lymphoid
organ
waldey
ring
human
nose
upper
airway
effect
captur
major
common
immunogen
particl
droplet
contain
pathogen
inhal
air
foreign
antigen
bacteria
virus
activ
local
mucos
immun
system
caus
sinonas
inflammatori
diseas
littl
known
immunolog
effect
tissu
distal
nose
upper
airway
especi
lung
order
examin
effect
intranas
infect
balbc
mice
pneumotrop
murin
coronaviru
cov
deliv
small
volum
nostril
normal
inocul
volum
avoid
aspir
fail
recov
viru
lung
cours
nasal
mucosa
import
compon
mucos
immun
immunogen
particl
inspir
air
known
activ
local
nasal
mucos
immun
system
lead
sinonas
inflamm
howev
littl
known
effect
activ
lung
immun
environ
show
nasal
inocul
murin
coronaviru
cov
absenc
direct
lung
infect
prime
lung
immun
environ
recruit
activ
monocyt
inflammatori
monocyt
nk
cell
lung
unlik
infiltr
cell
directli
infect
lung
process
requir
type
ifn
signal
nasal
induc
infiltr
inflammatori
monocyt
lung
ifni
independ
activ
macrophag
ingest
antigen
migrat
pulmonari
lymph
node
enhanc
innat
adapt
immun
heterolog
viru
infect
clinic
nasalonli
inocul
fail
caus
pneumonia
significantli
reduc
mortal
morbid
lethal
pneumonia
caus
sever
acut
respiratori
syndrom
cov
sarscov
influenza
viru
togeth
data
indic
nose
upper
airway
remot
prime
lung
immun
protect
lung
direct
viral
infect
experi
use
either
realtim
quantit
rtpcr
qrtpcr
viru
titrat
lung
diseas
absent
strikingli
limit
local
nasal
infect
significantli
reduc
mortal
rate
challeng
heterolog
pathogen
respiratori
virus
sarscov
iav
reduc
clinic
diseas
observ
signific
increas
number
inflammatori
monocyt
im
lung
day
nasal
infect
moreov
im
recruit
lowvolum
nasal
infect
less
activ
proinflammatori
compar
detect
direct
lung
infect
result
suggest
monocyt
dramat
enhanc
innat
virusspecif
cell
respons
heterolog
viru
challeng
find
indic
activ
nasal
innat
immun
respons
may
use
prevent
treatment
lethal
viral
pneumonia
nasal
administr
dramat
reduc
mortal
morbid
heterolog
viru
infect
deliv
mous
hepat
viru
type
pfu
intranas
small
volum
nostril
gener
nasalonli
inocul
supplement
figur
supplement
materi
avail
onlin
articl
http
use
amount
inoculum
detect
virus
nasal
lavag
fluid
nlf
day
infect
pi
detect
viru
lung
cours
experi
supplement
figur
viru
detect
lung
plaqu
assay
qrtpcr
clinic
mice
nasal
inoculum
lose
weight
supplement
figur
display
sign
pneumonia
cell
number
supplement
figur
differenti
bronchoalveolar
fluid
balf
mice
intranas
indistinguish
compar
control
mice
intranas
treat
vehicl
major
cell
type
balf
group
alveolar
macrophag
defin
high
autofluoresc
siglecf
express
describ
previous
group
cell
b
cell
neutrophil
nk
cell
cell
balf
data
shown
addit
nasal
infect
caus
signific
lymphocyt
expans
cervic
lymph
node
mln
consist
presenc
viru
upper
airway
lung
supplement
figur
sinc
fail
observ
sign
direct
viru
infect
lung
intranas
inocul
pfu
use
volumedos
subsequ
experi
design
nasalonli
inocul
next
analyz
earli
immun
respons
nasalassoci
lymphoid
tissu
nalt
supplement
figur
superfici
deep
cervic
lymph
node
within
hour
nasalonli
inocul
observ
upregul
b
cell
express
supplement
figur
one
earliest
event
nalt
nasalonli
inocul
suggest
b
cell
activ
bt
cell
ratio
b
cell
frequenc
number
nalt
cervic
lymph
node
significantli
reduc
within
hour
pi
supplement
figur
il
suggest
b
cell
egress
nalt
contribut
immun
respons
distant
organ
lung
next
examin
whether
nasalonli
inocul
could
modul
mortal
morbid
lethal
pneumonia
sarscov
iav
balbc
mice
intranas
treat
pfu
two
day
later
mice
intratrach
infect
unrel
virus
iav
sarscov
lethal
dose
prior
nasal
inocul
dramat
reduc
mortal
rate
sarscov
pneumonia
figur
morbid
repres
weight
loss
significantli
reduc
figur
wherea
kinet
sarscov
clearanc
significantli
enhanc
fold
lung
mice
prior
nasal
inocul
mhvsarscov
figur
histolog
mice
without
prior
nasal
inocul
exhibit
evid
extens
alveolar
damag
character
alveolar
edema
inflamm
vascular
congestionhemorrhag
mice
prior
nasal
mhv
inoculum
minor
interstiti
inflamm
minor
vascular
congest
observ
figur
dg
extend
result
noncov
infect
infect
mice
mouseadapt
iav
strain
tissu
cultur
infecti
unit
tciu
per
mous
via
instil
follow
prime
similar
sarscov
infect
prior
nasal
inocul
significantli
reduc
iav
pneumoniainduc
mortal
figur
weight
loss
figur
clinic
score
figur
lung
histolog
examin
reveal
less
sever
alveolar
wall
damag
group
prior
inocul
figur
kn
taken
togeth
data
indic
nasalonli
inocul
gener
robust
protect
lethal
pneumonia
caus
heterolog
virus
nasalonli
inocul
remot
prime
lung
innat
immun
recruit
im
determin
whether
protect
effect
accompani
chang
infiltr
cell
composit
analyz
mous
lung
day
total
cell
number
lung
chang
nasalonli
inocul
figur
cellular
composit
significantli
alter
decreas
frequenc
b
cell
increas
frequenc
im
int
int
siglecf
bluefil
repres
neg
control
hi
cell
siglecf
int
neut
neutrophil
cell
b
b
cell
nk
nk
cell
alveolar
macrophag
eg
local
im
lung
balbc
mice
intranas
infect
pfu
mem
vehicl
sacrif
dpi
left
lung
clamp
right
pulmonari
vessel
exclus
perfus
via
right
ventricl
e
frequenc
im
left
right
lung
analyz
express
percentag
singlet
cell
f
g
p
vs
control
n
per
group
im
accumul
nasalonli
inocul
could
present
lung
parenchyma
alveolar
space
blood
vessel
distinguish
possibl
perform
unilater
perfus
pulmonari
vessel
examin
whether
intervent
chang
frequenc
cell
comparison
nonperfus
side
anim
figur
shown
figur
f
g
frequenc
cell
chang
perfus
pulmonari
circul
indic
circul
pulmonari
blood
vessel
although
could
still
adher
vessel
wall
lymphat
vessel
lack
chang
cell
number
supplement
figur
differenti
balf
nasalonli
inocul
suggest
im
situat
primarili
lung
parenchyma
pulmonari
vessel
alveolar
space
nasalonli
inoculationinduc
infiltr
inflammatori
monocyt
lung
ifni
independ
previou
studi
shown
recruit
im
site
viru
infect
lung
ifni
depend
order
determin
whether
im
infiltr
lung
nasalonli
inocul
also
ifni
depend
infect
mice
lack
ifni
receptor
balbc
ifnar
balbc
control
intranas
pfu
pfu
vehicl
lung
analyz
day
pi
figur
expect
direct
lung
infect
pfu
significantli
increas
accumul
im
lung
wt
mice
ifnar
mice
mark
contrast
mice
intranas
prime
im
equival
infiltr
lung
ifnar
wt
mice
recent
studi
demonstr
import
role
vagu
nerv
regul
excess
immun
respons
gi
tract
lung
next
assess
whether
vagu
nerv
similar
role
nasalonli
inocul
perform
unilater
cervic
vagotomi
contralater
side
shamtreat
without
vagotomi
mice
intranas
treat
pfu
day
later
shown
supplement
figur
nearli
ident
im
infiltr
lung
vagotom
shamtreat
side
anim
taken
togeth
data
indic
im
recruit
lung
nasal
prime
ifniand
vagu
nerveindepend
thu
mechanist
differ
caus
direct
lung
infect
im
recruit
nasalonli
inocul
less
activatedmatur
recruit
infect
next
compar
express
level
activationmatur
marker
includ
mhc
class
ii
mhcii
im
recruit
nasalonli
oppos
infect
shown
figur
ac
nasalonli
infect
result
nearli
ident
frequenc
number
im
lung
day
pi
howev
mice
nasalonli
inocul
express
level
mhcii
im
increas
lesser
degre
infect
figur
indic
cell
less
activatedmatur
recruit
direct
lung
infect
im
recruit
nasal
prime
produc
tnf
previou
studi
shown
secret
tnf
one
major
antivir
mechan
employ
im
assess
whether
im
recruit
nasal
prime
produc
tnf
harvest
lungderiv
cell
day
pi
treat
lp
vehicl
hour
directli
ex
vivo
follow
intracellular
stain
tnf
absenc
lp
treatment
im
noninfect
mice
produc
tnf
differ
isotypestain
cell
tnf
antibodytr
cell
group
figur
lp
stimul
mice
nasalonli
inocul
exhibit
significantli
tnfsecret
im
lung
comparison
noninfect
control
figur
ac
differ
amount
tnf
express
per
cell
howev
base
measur
mfi
data
shown
data
show
increas
lpsinduc
tnf
product
im
recruit
lung
follow
nasalonli
inocul
suggest
nasal
exposur
virusprim
immun
cell
lung
gener
robust
innat
immun
respons
pathogen
increas
tnf
mice
nasalonli
inocul
sarscov
infect
assess
whether
prior
nasalonli
inocul
gener
robust
innat
immun
respons
sarscov
challeng
infect
mice
intranas
challeng
sarscov
day
pi
shown
figur
b
tnf
level
dramat
increas
hour
sarscov
infect
mice
support
notion
nasalonli
inocul
enhanc
lung
innat
immun
respons
lethal
viru
infect
migrat
lung
im
mice
nasalonli
inocul
sinc
infiltr
im
may
function
apc
orchestr
adapt
immun
next
examin
whether
intranas
prime
also
augment
apc
number
function
nasalonli
inocul
number
im
lung
increas
vs
control
fraction
express
also
increas
figur
ac
sinc
express
requir
apc
migrat
drain
lymph
node
next
instil
ovafitc
lung
mice
analyz
mediastin
lymph
node
mln
hour
later
fitc
cell
migrat
mice
nasal
infect
control
exhibit
fitc
im
mln
figur
df
demonstr
im
recruit
nasal
inocul
prime
antigen
uptak
migrat
mln
enhanc
adapt
immun
respons
heterolog
viru
challeng
lung
nasal
infect
assess
whether
enhanc
im
migrat
mln
result
stronger
cell
respons
lung
mice
treat
mice
intranas
day
prior
challeng
lethal
dose
sarscov
sarscovspecif
cell
respons
investig
use
intracellular
cytokin
stain
assay
stimul
virusspecif
peptid
cell
cell
shown
figur
prior
nasal
inocul
significantli
enhanc
sarscovspecif
cell
respons
lung
suggest
enhanc
cell
respons
result
nasal
prime
one
possibl
mechan
underli
observ
protect
viral
pneumonia
report
demonstr
intranas
exposur
low
volum
pneumotrop
neurotrop
murin
cov
remot
prime
immun
environ
lung
increas
infiltr
im
absenc
direct
pulmonari
infect
cell
comparison
recruit
direct
viral
infect
lung
less
activ
thu
less
proinflammatori
express
lower
level
mhcii
howev
lp
stimul
cell
abl
secret
tnf
lung
suggest
role
initi
enhanc
innat
immun
respons
also
exhibit
abil
ingest
antigen
migrat
mln
enhanc
cell
respons
heterolog
viral
infect
lung
result
nasal
prime
dramat
reduc
mortal
morbid
result
subsequ
lethal
infect
sarscov
iav
major
physiolog
role
human
nose
protect
lung
result
reveal
addit
warm
humidifi
filter
inspir
air
immunolog
prime
anoth
lungprotect
mechan
initi
nose
upper
airway
immun
prime
lung
prior
pulmonari
infect
previous
describ
instanc
iav
infect
mice
diminish
clinic
patholog
consequ
subsequ
respiratori
syncyti
viru
infect
pulmonari
treatment
immunogen
substanc
poli
c
cpg
gener
protect
subsequ
lethal
pneumonia
caus
unrel
pathogen
includ
iav
sarscov
middl
east
respiratori
syndrom
cov
merscov
studi
show
nasalonli
exposur
mous
cov
prime
lung
environ
prime
phenomenon
appear
restrict
mhvjhm
neurotrop
viru
primarili
caus
enceph
pneumonia
also
recruit
antivir
monocyt
lung
contrast
previou
report
direct
inocul
lung
occur
aspir
data
indic
indirect
remot
prime
lung
environ
viral
exposur
nose
prepar
lung
robust
infect
rigor
exclud
possibl
lung
exposur
viru
fail
detect
lung
use
either
qrtpcr
viral
titrat
fail
find
clinic
evid
direct
lung
infect
interact
upper
lower
airway
long
observ
instanc
allerg
rhiniti
singl
import
risk
factor
asthma
nasal
allergen
provoc
patient
allerg
rhiniti
upregul
express
eselectin
bronchial
tissu
common
cold
frequent
caus
asthma
exacerb
howev
mechan
inflamm
nose
impact
lung
remain
poorli
understood
recent
neuroimmun
interact
postul
play
import
role
regul
innat
immun
respons
infecti
environment
pathogen
kradin
et
al
show
pulmonari
dc
normal
locat
immedi
proxim
unmyelin
nerv
capsaicin
neurotox
protein
effect
inhibit
accumul
dc
inflammatori
cell
around
small
pulmonari
vessel
exposur
inhal
antigen
nose
lung
connect
nasobronchi
reflex
consist
affer
signal
carri
trigemin
nerv
nose
effer
signal
carri
vagu
nerv
lung
howev
unabl
provid
experiment
data
support
role
prime
via
nasobronchi
reflex
sinc
unilater
cervic
vagotomi
diminish
im
infiltr
lung
nasalonli
inocul
supplement
figur
b
cross
talk
distinct
distant
mucos
site
previous
report
schuijt
et
al
show
gi
mucos
system
play
critic
role
regul
lung
immun
sinc
deplet
gut
microbiota
associ
increas
bacteri
dissemin
decreas
tnf
secret
increas
organ
damag
mortal
pneumococc
pneumonia
phenotyp
alter
gut
microbiotadeplet
mice
complet
revers
fecal
microbiota
transplant
group
also
report
similar
crossmucos
interact
howev
underli
mechan
remain
poorli
understood
may
involv
b
cell
activ
johansen
et
al
show
activ
b
cell
human
tonsil
preferenti
migrat
distal
mucos
site
lower
airway
lacrim
gland
salivari
gland
vagina
heidegg
et
al
show
viral
infect
gut
also
caus
earli
reduct
b
cell
number
peyer
patch
mesenter
lymph
node
reduct
abolish
mice
pretreat
compound
inhibit
b
cell
egress
secondari
lymphoid
organ
studi
show
role
b
cell
innat
immun
instanc
harvey
et
al
show
b
cell
transfer
antigen
apc
especi
macrophag
bao
et
al
report
b
cell
directli
stimul
macrophag
play
import
role
innat
immun
b
cell
also
respons
format
mucosaassoci
lymphoid
tissu
malt
stomach
h
pylori
infect
data
demonstr
earli
activ
possibl
egress
b
cell
nalt
nasalonli
inocul
howev
whether
b
cell
nalt
act
messeng
nose
lung
therebi
prime
lung
immun
requir
investig
supplement
figur
gl
mount
evid
demonstr
protect
pathogen
role
im
host
respons
differ
viral
diseas
includ
respiratori
syncyti
viru
rsv
pneumonia
vagin
iav
pneumonia
keratoconjunct
cytomegaloviru
hepat
goritzka
et
al
report
rsv
infect
recruit
protect
im
via
alveolar
macrophagederiv
type
ifn
mice
vagin
absenc
chemokin
receptor
requir
im
egress
bone
marrow
entri
site
inflamm
result
significantli
higher
viral
titer
vagina
dramat
higher
mortal
rate
compar
control
anoth
studi
deplet
im
dc
myeloid
cell
result
higher
suscept
infect
contrast
robust
immunopathogen
role
im
mice
infect
sarscov
demonstr
result
increas
lethal
sever
hypothes
propos
differ
effect
cell
first
im
migrat
ifni
depend
time
ifni
induct
may
influenc
extent
im
accumul
delay
ifni
signal
associ
accumul
pathogen
im
lung
sarscov
infect
second
amount
infiltr
im
may
influenc
outcom
aldridg
et
al
show
moder
infiltr
im
lung
protect
mice
lethal
iav
pneumonia
howev
excess
infiltr
elimin
cell
detriment
due
associ
immunopatholog
reduc
cell
respons
respect
qualiti
infiltr
im
may
also
contribut
outcom
studi
nasalonli
inocul
instil
caus
compar
infiltr
im
lung
im
driven
nasalonli
inocul
less
matur
proinflammatori
compar
driven
instil
im
prevent
diseas
lowdos
mice
yet
understood
im
enhanc
apoptosi
lung
epitheli
cell
iav
infect
tnfrelat
apoptosisinduc
liganddeathinduc
receptor
pathway
also
implic
develop
iavspecif
cell
respons
im
also
shown
activ
nk
cell
via
mechan
mous
model
vagin
observ
increas
product
tnf
im
earli
infiltr
activ
nk
cell
lung
mice
nasal
exposur
supplement
figur
also
observ
increas
express
im
increas
abil
ingest
antigen
migrat
lung
drain
lymph
node
significantli
enhanc
cell
respons
lung
heterolog
viru
infect
summari
demonstr
nasal
exposur
coronaviru
remot
prime
lung
immun
absenc
direct
lung
infect
prime
provid
effect
protect
subsequ
lethal
viral
infect
lung
data
reveal
earli
exposur
pathogen
nose
upper
airway
immunolog
prepar
lung
rapid
initi
innat
adapt
immun
respons
homolog
heterolog
infect
clinic
epidemiolog
evid
support
concept
unifi
airway
underli
pathobiolog
remain
poorli
understood
data
implic
crosstalk
distant
mucos
site
nose
lung
suggest
common
mucos
immun
system
mechan
connect
nose
lung
find
may
import
therapeut
implic
use
nasal
immunotherapi
prevent
reduc
sever
viral
pneumonia
present
caus
signific
morbid
mortal
limit
therapeut
option
treatment
use
nasal
prime
need
care
tailor
individu
patient
exampl
tnf
key
nasal
prime
approach
would
use
patient
treat
infliximab
etanercept
inhibit
tnf
signal
investig
advanc
understand
airway
mucos
immunolog
may
also
help
open
novel
direct
manag
lower
airway
diseas
defin
limit
nasal
immunotherapi
mice
balbc
mice
purchas
nation
cancer
institut
nci
hous
bred
specif
pathogenfre
facil
univers
iowa
light
cycl
mice
use
studi
femal
food
water
provid
ad
libitum
mice
throughout
durat
studi
ifnar
balbc
mice
provid
joan
durbin
rutger
new
jersey
medic
school
newark
new
jersey
usa
viral
infect
mous
coronaviru
jhm
strain
propag
previous
describ
mous
adapt
influenza
viru
iav
provid
kevin
legg
univers
iowa
prepar
describ
previous
mouseadapt
sarscov
obtain
kanta
subbarao
nih
bethesda
maryland
usa
intranas
infect
first
determin
volum
caus
aspir
balbc
mice
intranas
treat
evan
blue
pb
indic
volum
light
anesthesia
use
isofluran
prior
euthan
minut
later
balf
obtain
assay
evan
blue
use
spectrophotomet
separ
experi
radiolabel
sulfur
colloid
solut
per
nostril
intranas
administ
mice
light
anesthesia
use
isofluran
radioact
determin
scintigraph
minut
later
base
result
use
per
nostril
contain
pfu
nasalonli
inocul
light
anesthesia
isofluran
instil
balbc
mice
anesthet
isofluran
hung
vertic
upper
incisor
tower
tongu
gentli
retract
viral
solut
pipet
hypopharynx
viral
titrat
viral
titer
determin
standard
plaqu
assay
use
hela
cell
stabli
transfect
mhv
receptor
describ
previous
sarscov
titer
determin
use
vero
cell
describ
previous
viral
titer
express
pfug
qrtpcr
rna
isol
whole
mous
lung
homogen
trizol
use
standard
protocol
cdna
creat
normal
sampl
rna
qrtpcr
perform
appli
biosystem
system
use
sybr
green
rox
qpcr
mastermix
qiagen
previous
describ
primer
locat
within
specif
genom
rna
fwd
rev
use
measur
express
genom
rna
sampl
ct
valu
mockinfect
mice
consid
neg
viral
genom
rna
cytokin
measur
whole
lung
infect
control
use
antibodi
flow
cytometri
follow
antibodi
use
studi
whole
lung
lavag
nasal
lavag
unilater
vagotomi
singlecel
suspens
isol
cervic
lymph
node
mln
nalt
whole
lung
lavag
perform
describ
previous
nlf
mice
decapit
euthanasia
exsanguin
mandibl
remov
expos
posterior
open
nasopharyng
tube
oropharynx
cathet
insert
nasopharynx
one
millilit
pb
use
lavag
nasal
caviti
unilater
vagotomi
perform
describ
previous
gener
anesthesia
nalt
cervic
lymph
node
mln
isol
standard
fashion
microscop
lung
singlecel
suspens
gener
per
standard
protocol
briefli
lung
minc
digest
hbss
contain
mgml
dnase
roch
mgml
collagenas
roch
fc
mm
hepe
room
temperatur
minut
digest
tissu
gentli
dispers
pass
nylon
filter
prepar
singlecel
suspens
intracellular
cytokin
stain
detect
tnf
product
im
mice
infect
intranas
pfu
vehicl
two
day
later
mice
sacrif
singlecel
suspens
lung
prepar
cell
treat
lp
vehicl
presenc
golgiplug
bd
hour
surfac
stain
follow
cell
fixat
permeabil
bd
cytofixcytoperm
intracellular
stain
perform
use
antitnf
antibodi
pe
bd
bioscienc
isotyp
use
gate
sampl
cell
migrat
drain
lymph
node
evalu
migrat
im
lung
mln
balbc
mice
infect
intranas
pfu
vehicl
two
day
later
ovafitc
instil
lung
ovafitcposit
im
mln
assay
hour
later
surviv
clinic
score
lung
histolog
viral
infect
mice
monitor
daili
morbid
mortal
mice
greater
weight
loss
euthan
per
institut
iacuc
protocol
clinic
ill
determin
blindli
use
grade
system
follow
healthi
huddl
reduc
activ
inact
ruffl
fur
emaci
dead
lung
histolog
perform
describ
previous
statist
data
express
mean
sem
twotail
unpair
student
test
use
analyz
differ
mean
valu
group
anova
use
comparison
among
group
weight
loss
analyz
use
repeatedmeasur
anova
least
signific
differ
lsd
use
multipl
comparison
logrank
mantelcox
test
gehanbreslowwilcoxon
test
use
analyz
differ
surviv
p
consid
signific
studi
approv
anim
care
experiment
procedur
use
studi
approv
iacuc
univers
iowa
xh
sp
np
conceiv
idea
xh
st
rv
ja
sp
design
experi
xh
rv
ja
rc
perform
experi
dkm
perform
histolog
analysi
xh
sp
wrote
manuscript
